amifostine anhydrous has been researched along with Abnormalities, Radiation-Induced in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Abnormalities, Radiation-Induced: Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guelman, LR | 1 |
| Zorrilla Zubilete, MA | 1 |
| Rios, H | 1 |
| Zieher, LM | 1 |
1 other study available for amifostine anhydrous and Abnormalities, Radiation-Induced
| Article | Year |
|---|---|
WR-2721 (amifostine, ethyol) prevents motor and morphological changes induced by neonatal X-irradiation.
Topics: Abnormalities, Radiation-Induced; Amifostine; Animals; Animals, Newborn; Brain Chemistry; Calbindins | 2003 |